PROTEIN-BINDING AND CSF PENETRATION OF PHENYTOIN FOLLOWING ACUTE ORAL DOSING IN MAN

被引：18

作者：

BRODIE, MJ ^{[1
]}

MUIR, SE ^{[1
]}

AGNEW, E ^{[1
]}

MACPHEE, GJA ^{[1
]}

VOLO, G ^{[1
]}

TEASDALE, E ^{[1
]}

MACPHERSON, P ^{[1
]}

机构：

[1] SO GEN HOSP,DEPT NEURORADIOL,GLASGOW G51 4TF,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 19卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1985.tb02627.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：161 / 168

页数：8

相关论文

共 23 条

[11] PLASMA-PROTEIN BINDING OF PHENYTOIN IN 100 EPILEPTIC PATIENTS
PETERSON, GM
MCLEAN, S
ALDOUS, S
VONWITT, RJ
MILLINGEN, KS
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) : 298 - 300
[12] PLASMA PROTEIN-BINDING AND CSF CONCENTRATIONS OF VALPROIC ACID IN MAN FOLLOWING ACUTE ORAL DOSING
RAPEPORT, WG
MENDELOW, AD
FRENCH, G
MACPHERSON, P
TEASDALE, E
AGNEW, E
THOMPSON, GG
BRODIE, MJ
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (04) : 365 - 369
[13] CHRONIC ANTIEPILEPTIC TOXICITY - REVIEW
REYNOLDS, EH
[J]. EPILEPSIA, 1975, 16 (02) : 319 - 352
[14] RICHENS A, 1975, LANCET, V2, P247
[15] CLINICAL PHARMACOKINETICS OF PHENYTOIN
RICHENS, A
[J]. CLINICAL PHARMACOKINETICS, 1979, 4 (03) : 153 - 169
[16] RICHENS A, 1981, THERAPEUTIC DRUG MON, P320
[17] SHOULD WE ROUTINELY MEASURE FREE PLASMA PHENYTOIN CONCENTRATION
RIMMER, EM
BUSS, DC
ROUTLEDGE, PA
RICHENS, A
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (01) : 99 - 102
[18] PLASMA-PROTEIN BINDING AND THERAPEUTIC DRUG-MONITORING
ROWLAND, M
[J]. THERAPEUTIC DRUG MONITORING, 1980, 2 (01) : 29 - 37
[19] INFLUENCE OF DH-DL ALLELES REGULATING DEBRISOQUINE OXIDATION ON PHENYTOIN HYDROXYLATION
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) : 493 - 497
[20] TEASDALE E, 1984, BR J RADIOL